Company profile: Core Diagnostics
1.1 - Company Overview
Company description
- Provider of full-service esoteric pathology laboratory services; a venture capital-backed laboratory based in Hayward, California.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Core Diagnostics
Humaneva
HQ: United States
Website
- Description: Provider of integrated clinical research solutions: Pratia, a network of clinical trial centers expanding patient access to innovative treatments, particularly in oncology; Kapadi, a CRO managing biotechnological oncology projects including gene and cell therapy research; and Hyggio, a clinical trial software platform with data analytics, eSource, CTMS, and remote monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Humaneva company profile →
PMG Research
HQ: United States
Website
- Description: Provider of integrated clinical research through a network of facilities operating from 12 U.S. metropolitan areas, conducting trials since 1979. Offerings include Accellacare studies on medical conditions such as migraines, post-surgical neuropathy, and COVID-19 vaccines; The Patient Voice feedback program; Lunch and Learn; and Tell a Friend referral program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PMG Research company profile →
INCOG BioPharma Services
HQ: United States
Website
- Description: Provider of injectable drug product services, including formulation development, analytical method development, process scale up, and formulation/filling of vials, syringes, and cartridges for clinical and commercial manufacturing. Offers QC chemistry and microbiology testing, inspection, labeling, packaging, device assembly, and material/finished product storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full INCOG BioPharma Services company profile →
Certis Oncology
HQ: United States
Website
- Description: Provider of precision oncology and translational science solutions, including Certis Oncology Intelligence® for predictive therapeutic response data from advanced cancer models with AI-driven bioinformatics; BarneyOI® cancer model database; CertisAI™ drug response prediction; O-PDX models; 3D cell cultures; and custom in vitro pharmacology and ex vivo assays, including cell line development, to help bridge the preclinical–clinical translation gap.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Certis Oncology company profile →
Biopta
HQ: United Kingdom
Website
- Description: Provider of human tissue-based contract research services for drug development, using ethically donated fresh human tissues from surgery to predict drug behavior and bridge animal studies and clinical trials. Services include fresh human tissue pharmacology, a digital human tissue assay catalog, Alvetex 3D tissue models, REPROSKIN full-thickness skin, neurite outgrowth models, and clinical lab services with AI-driven biospecimen analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biopta company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Core Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Core Diagnostics
2.2 - Growth funds investing in similar companies to Core Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Core Diagnostics
4.2 - Public trading comparable groups for Core Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →